{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:43:46Z","timestamp":1789101826461,"version":"build-2803163510"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1004578","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T18:46:43Z","timestamp":1448477203000},"page":"e1004578","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":65,"title":["Towards a Molecular Understanding of the Link between Imatinib Resistance and Kinase Conformational Dynamics"],"prefix":"10.1371","volume":"11","author":[{"given":"Silvia","family":"Lovera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Morando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Encarna","family":"Pucheta-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge L.","family":"Martinez-Torrecuadrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Saladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco L.","family":"Gervasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd839","article-title":"Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug","volume":"1","author":"R Capdeville","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","article-title":"Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"108","author":"M Baccarani","year":"2006","journal-title":"Blood"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1002\/cncr.26568","article-title":"Very long-term follow-up results of imatinib mesylate therapy in chronic phase chronic myeloid leukemia after failure of interferon alpha therapy","volume":"118","author":"H Kantarjian","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1280","article-title":"Regulation of the c-Abl and Bcr-Abl tyrosine kinases","volume":"5","author":"O Hantschel","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"M Deininger","year":"2005","journal-title":"Blood"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/13543784.2011.546344","article-title":"Mechanisms of drug resistance in kinases","volume":"20","author":"R Barouch-Bentov","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"e1000487","DOI":"10.1371\/journal.pcbi.1000487","article-title":"Hierarchical modeling of activation mechanisms in the ABL and EGFR kinase domains: thermodynamic and mechanistic catalysts of kinase activation by cancer mutations","volume":"5","author":"A Dixit","year":"2009","journal-title":"PLoS Comput Biol"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"e1002179","DOI":"10.1371\/journal.pcbi.1002179","article-title":"Computational modeling of allosteric communication reveals organizing principles of mutation-induced signaling in ABL and EGFR kinases","volume":"7","author":"A Dixit","year":"2011","journal-title":"PLoS Comput Biol"},{"issue":"5531","key":"ref9","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"ME Gorre","year":"2001","journal-title":"Science"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1073\/pnas.0709662105","article-title":"The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP","volume":"105","author":"CH Yun","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nsmb.1486","article-title":"Activation of tyrosine kinases by mutation of the gatekeeper threonine","volume":"15","author":"M Azam","year":"2008","journal-title":"Nat Struct Mol Biol"},{"issue":"26","key":"ref12","doi-asserted-by":"crossref","first-page":"10616","DOI":"10.1073\/pnas.1221953110","article-title":"Effects of oncogenic mutations on the conformational free-energy landscape of EGFR kinase","volume":"110","author":"L Sutto","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ebiom.2015.02.009","article-title":"The Effect of Mutations on Drug Sensitivity and Kinase Activity of Fibroblast Growth Factor Receptors: A Combined Experimental and Theoretical Study","volume":"2","author":"TD Bunney","year":"2015","journal-title":"EBioMedicine"},{"issue":"6224","key":"ref14","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1126\/science.aaa1823","article-title":"Kinase dynamics. Using ancient protein kinases to unravel a modern cancer drug\u2019s mechanism","volume":"347","author":"C Wilson","year":"2015","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia","volume":"2","author":"NP Shah","year":"2002","journal-title":"Cancer Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0092-8674(03)00190-9","article-title":"Mechanisms of Autoinhibition and STI-571 \/ Imatinib Resistance Revealed by Mutagenesis of BCR-ABL","volume":"112","author":"M Azam","year":"2003","journal-title":"Cell"},{"issue":"24","key":"ref17","doi-asserted-by":"crossref","first-page":"9244","DOI":"10.1073\/pnas.0600001103","article-title":"Activity of dual SRC-ABL inhibitors highlights the role of BCR\/ABL kinase dynamics in drug resistance","volume":"103","author":"M Azam","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"ref18","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.1073\/pnas.0510426103","article-title":"Low-frequency normal modes that describe allosteric transitions in biological nanomachines are robust to sequence variations","volume":"103","author":"W Zheng","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1110\/ps.9.1.10","article-title":"Folding and binding cascades: dynamic landscapes and population shifts","volume":"9","author":"S Kumar","year":"2000","journal-title":"Protein Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1038\/ncomms6939","article-title":"A dynamically coupled allosteric network underlies binding cooperativity in Src kinase","volume":"6","author":"ZH Foda","year":"2015","journal-title":"Nat Comm"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nchembio799","article-title":"Rational design of inhibitors that bind to inactive kinase conformations","volume":"2","author":"Y Liu","year":"2006","journal-title":"Nat Chem Biol"},{"issue":"19","key":"ref22","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1007\/s00018-008-8122-2","article-title":"Structure and dynamic regulation of Src-family kinases","volume":"65","author":"JR Engen","year":"2008","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1073\/pnas.0811223106","article-title":"A conserved protonation-dependent switch controls drug binding in the Abl kinase","volume":"106","author":"Y Shan","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref24","first-page":"4236","article-title":"Crystal Structures of the Kinase Domain of c-Abl in Complex with the Small Molecule Inhibitors PD173955 and Imatinib Crystal Structures of the Kinase Domain of c-Abl in Complex with the Small","author":"B Nagar","year":"2002","journal-title":"Cancer"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.chembiol.2010.09.010","article-title":"Article Activation State-Dependent Binding of Small Molecule Kinase Inhibitors: Structural Insights from Biochemistry","volume":"17","author":"LM Wodicka","year":"2010","journal-title":"Chem Biol"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.str.2007.01.015","article-title":"c-Src binds to the cancer drug imatinib with an inactive Abl\/c-Kit conformation and a distributed thermodynamic penalty","volume":"15","author":"Ma Seeliger","year":"2007","journal-title":"Structure"},{"issue":"18","key":"ref27","doi-asserted-by":"crossref","first-page":"13807","DOI":"10.1074\/jbc.M110.109660","article-title":"Molecular Dynamics Simulations Show That Conformational Selection Governs the Binding Preferences of Imatinib for Several Tyrosine Kinases","volume":"285","author":"A Aleksandrov","year":"2010","journal-title":"J Biol Chem"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1073\/pnas.1214330110","article-title":"Explaining why Gleevec is a specific and potent inhibitor of Abl kinase","volume":"110","author":"YL Lin","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1021\/ja210751t","article-title":"The different flexibility of c-Src and c-Abl kinases regulates the accessibility of a druggable inactive conformation","volume":"134","author":"S Lovera","year":"2012","journal-title":"J Am Chem Soc"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"A Sali","year":"1993","journal-title":"J Mol Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple Amber force fields and development of improved protein backbone parameters","volume":"65","author":"V Hornak","year":"2006","journal-title":"Proteins: Struct Funct Bioinf"},{"issue":"8","key":"ref32","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"K Lindorff-larsen","year":"2010","journal-title":"Proteins"},{"issue":"26","key":"ref33","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/jp901540t","article-title":"Optimized molecular dynamics force fields applied to the helix-coil transition of polypeptides","volume":"113","author":"RB Best","year":"2009","journal-title":"J Phys Chem B"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/ja00392a016","article-title":"Transferable intermolecular potential functions for water, alcohols, and ethers. Application to liquid water","volume":"103","author":"WL Jorgensen","year":"1981","journal-title":"J Am Chem Soc"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1021\/ct9000685","article-title":"ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Time Scale","volume":"5","author":"MJ Harvey","year":"2009","journal-title":"J Chem Theory Comput"},{"issue":"41","key":"ref36","doi-asserted-by":"crossref","first-page":"13435","DOI":"10.1021\/ja062463w","article-title":"Free-energy landscape for beta hairpin folding from combined parallel tempering and metadynamics","volume":"128","author":"G Bussi","year":"2006","journal-title":"J Am Chem Soc"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"020603","DOI":"10.1103\/PhysRevLett.100.020603","article-title":"Well-tempered metadynamics: A smoothly converging and tunable free-energy method","volume":"100","author":"A Barducci","year":"2008","journal-title":"Phys Rev Lett"},{"issue":"19","key":"ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1103\/PhysRevLett.104.190601","article-title":"Enhanced Sampling in the Well-Tempered Ensemble","volume":"104","author":"M Bonomi","year":"2010","journal-title":"Phys Rev Lett"},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1021\/ct300297t","article-title":"Efficient Simulation of Explicitly Solvated Proteins in the Well-Tempered Ensemble","volume":"8","author":"M Deighan","year":"2012","journal-title":"J Chem Theory Comput"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"e1003863","DOI":"10.1371\/journal.pcbi.1003863","article-title":"The SH2 Domain Regulates c-Abl Kinase Activation by a Cyclin-Like Mechanism and Remodulation of the Hinge Motion","volume":"10","author":"N D\u00f6lker","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1021\/jacs.5b01421","article-title":"The Effect of a Widespread Cancer-Causing Mutation on the Inactive to Active Dynamics of the B-Raf Kinase","volume":"137","author":"KA Marino","year":"2015","journal-title":"J Am Chem Soc"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1021\/ct500536r","article-title":"Conformational Changes and Free Energies in a Proline Isomerase","volume":"10","author":"E Papaleo","year":"2014","journal-title":"J Chem Theory Comput"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"Gromacs 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"B Hess","year":"2008","journal-title":"J Chem Theory Comput"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.cpc.2009.05.011","article-title":"PLUMED: a portable plugin for free-energy calculations with molecular dynamics","volume":"180","author":"M Bonomi","year":"2009","journal-title":"Comp Phys Comm"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"14101","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"G Bussi","year":"2007","journal-title":"J Chem Phys"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1021\/jp504920s","article-title":"A time-independent free energy estimator for metadynamics","volume":"119","author":"P Tiwary","year":"2015","journal-title":"J Phys Chem B"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"054103","DOI":"10.1063\/1.2432340","article-title":"From A to B in free energy space","volume":"126","author":"D Branduardi","year":"2007","journal-title":"J Chem Phys"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1021\/ct501034w","article-title":"Efficient Determination of Relative Entropy Using Combined Temperature and Hamiltonian Replica-Exchange Molecular Dynamics","volume":"11","author":"S Jo","year":"2015","journal-title":"J Chem Theory Comput"},{"key":"ref49","article-title":"Gaussian 03, Revision C.02","author":"MJ Frisch","year":"2004"},{"issue":"17","key":"ref50","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2174\/156802612804547407","article-title":"New insights in protein kinase conformational dynamics","volume":"12","author":"G Saladino","year":"2012","journal-title":"Curr Tomp Med Chem"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1021\/ar500356n","article-title":"Investigating Drug\u2013Target Association and Dissociation Mechanisms Using Metadynamics-Based Algorithms","volume":"48","author":"A Cavalli","year":"2015","journal-title":"Acc Chem Res"},{"issue":"14","key":"ref52","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1021\/jp803936q","article-title":"Exploring Complex Protein-Ligand Recognition Mechanisms with Coarse Metadynamics","volume":"113","author":"M Masetti","year":"2009","journal-title":"The journal of physical chemistry B"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12104-011-9304-7","article-title":"Backbone assignment of the tyrosine kinase Src catalytic domain in complex with imatinib","volume":"5","author":"R Campos-Olivas","year":"2011","journal-title":"Biomol NMR Assign"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/blood-2002-09-2896","article-title":"Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis","volume":"102","author":"S Branford","year":"2003","journal-title":"Blood"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","article-title":"Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors","volume":"295","author":"E Buchdunger","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"ref56","first-page":"M11","article-title":"Bcr-Abl inhibition as a modality of CML therapeutics","volume":"1551","author":"E Buchdunger","year":"2001","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0960-894X(96)00601-4","article-title":"Potent and selective inhibitors of the Abl-kinase: phenylamino-pyrimidine (PAP) derivatives","volume":"7","author":"J Zimmermann","year":"1997","journal-title":"Bioorg Med Chem Lett"},{"issue":"5486","key":"ref58","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.289.5486.1938","article-title":"Structural mechanism for STI-571 inhibition of abelson tyrosine kinase","volume":"289","author":"T Schindler","year":"2000","journal-title":"Science (80-)"},{"issue":"7","key":"ref59","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2006-02-004580","article-title":"Comparison of imatinib mesylate, dasatinib (BMS-354825), and nilotinib (AMN107) in an N-ethyl-N-nitrosourea (ENU)\u2013based mutagenesis screen: high efficacy of drug combinations","volume":"108","author":"HA Bradeen","year":"2006","journal-title":"Blood"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(01)00301-4","article-title":"Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation","volume":"105","author":"Ma Young","year":"2001","journal-title":"Cell"},{"issue":"7280","key":"ref61","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature08675","article-title":"Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors","volume":"463","author":"J Zhang","year":"2010","journal-title":"Nature"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1158\/0008-5472.CAN-08-3953","article-title":"Equally potent inhibition of c-Src and Abl by compounds that recognize inactive kinase conformations","volume":"69","author":"Ma Seeliger","year":"2009","journal-title":"Cancer Res"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2012.02.063","article-title":"Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization","volume":"149","author":"Y Shan","year":"2012","journal-title":"Cell"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jmb.2013.10.001","article-title":"Locking the Active Conformation of c-Src Kinase through the Phosphorylation of the Activation Loop","volume":"426","author":"Y Meng","year":"2014","journal-title":"J Mol Biol"},{"issue":"8","key":"ref65","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1158\/1535-7163.MCT-08-1219","article-title":"Double EGFR mutants containing rare EGFR mutant types show reduced in vitro response to gefitinib compared with common activating missense mutations","volume":"8","author":"IYS Tam","year":"2009","journal-title":"Mol Cancer Ther"},{"issue":"22","key":"ref66","doi-asserted-by":"crossref","first-page":"12570","DOI":"10.1073\/pnas.2135471100","article-title":"Nonlinear elasticity, proteinquakes, and the energy landscapes of functional transitions in proteins","volume":"100","author":"O Miyashita","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"ref67","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1073\/pnas.1220843110","article-title":"Transitions to catalytically inactive conformations in EGFR kinase","volume":"110","author":"Y Shan","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"ref68","doi-asserted-by":"crossref","first-page":"e8470","DOI":"10.1371\/journal.pone.0008470","article-title":"Steered molecular dynamics simulations reveal the likelier dissociation pathway of imatinib from its targeting kinases c-Kit and Abl","volume":"4","author":"LJ Yang","year":"2009","journal-title":"PLoS ONE"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1004578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T14:51:11Z","timestamp":1748703071000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1004578"}},"subtitle":[],"editor":[{"given":"Anders","family":"Wallqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":68,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1004578","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,25]]}}}